Cosmax NBT Inc
KOSDAQ:222040
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cosmax NBT Inc
KOSDAQ:222040
|
KR |
|
XBiotech Inc
F:4XB
|
US |
|
O
|
Oncolytics Biotech Inc
NASDAQ:ONCY
|
CA |
|
A
|
Aethlon Medical Inc
F:EJU
|
US |
|
G
|
Grupo Nagoin SA de CV
BMV:EDUCA18
|
MX |
|
Detskiy Mir PAO
MOEX:DSKY
|
RU |
|
D
|
Damon Inc
NASDAQ:DMN
|
UK |
|
Ausgold Ltd
F:AU4
|
AU |
|
ONEOK Inc
NYSE:OKE
|
US |
|
P
|
Philippine Metals Inc
XTSX:PHI
|
CA |
|
Vertical Aerospace Ltd
NYSE:EVTL
|
UK |
Wall St Price Targets
Price Targets Summary
Cosmax NBT Inc
According to Wall Street analysts, the average 1-year price target for Cosmax NBT Inc is 12 240 KRW with a low forecast of 12 120 KRW and a high forecast of 12 600 KRW.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Cosmax NBT Inc's stock price target?
Price Target
12 240
KRW
According to Wall Street analysts, the average 1-year price target for Cosmax NBT Inc is 12 240 KRW with a low forecast of 12 120 KRW and a high forecast of 12 600 KRW.
What is the Revenue forecast for Cosmax NBT Inc?
Projected CAGR
26%
Over the last 12 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 2 years is 26%.
What is the Gross Profit forecast for Cosmax NBT Inc?
Projected CAGR
35%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 2 years is 35%.
What is the Operating Income forecast for Cosmax NBT Inc?
Projected CAGR
229%
Over the last 12 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 2 years is 229%.
